Email this article 
Hide
Show all
Original Research
Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa
Submitted: 13 September 2015 | Published: 31 May 2016
About the author(s)
Babatunde O. Sonuga, Division of Family Medicine, School of Public Health and Family Medicine, University of Cape Town, South AfricaDerek A. Hellenberg, Division of Family Medicine, School of Public Health and Family Medicine, University of Cape Town, South Africa
Clint S. Cupido, Department of Medicine, Victoria Hospital and Department of Medicine, University of Cape Town, South Africa
Cilia Jaeger, Department of Medicine, Victoria Hospital, South Africa and Department of Biotechnology, Drexel University, United States
Abstract
Background: Warfarin is the most frequently used oral anticoagulant worldwide and it is the oral anticoagulant of choice in South Africa for reducing thrombosis-related morbidity and mortality. However, the safety and efficacy of warfarin therapy depends mainly on careful monitoring and maintenance of the international normalised ratio (INR) within an optimal therapeutic range.
Aim: The aim of this study was to describe the profile and the anticoagulation outcomes of patients on warfarin therapy in a major warfarin clinic in the Western Cape Province of South Africa. Setting: Victoria Hospital - a district hospital in Cape Town. Methods: A cross sectional review of clinical records of patients on warfarin therapy who attended the INR clinic from 01 January 2014 to 30 June 2014 was done. Data analysis was done with STATA to generate appropriate descriptive data.
Results: Our study showed that atrial fibrillation (AF) was the commonest indication for warfarin use in this study and hypertension was the commonest comorbidity among these patients. Only 48.5% achieved target therapeutic range; 51.5% were out-of-range. There was a significant association between alcohol consumption and poor anticoagulation outcomes (p-value < 0.022). Anticoagulation outcomes were better among the older age groups, male patients and in those with AF. The prevalence of thrombotic events while on warfarin treatment was 2.2%, while prevalence of haemorrhagic events was 14%. Most of the patients with bleeding events were on concurrent use of warfarin and other medications with potential drug interactions.
Conclusion: In our study, patients who achieved target therapeutic control were less than the acceptable 60%.
Keywords: Oral anticoagulant, anticoagulation outcomes, therapeutic control, percentage INR within target therapeutic range (%ITTR),Time in therapeutic range (TIR)
Keywords
Metrics
Total abstract views: 6500Total article views: 8088
Crossref Citations
1. Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: Observations on quality of anticoagulation and thrombotic risk
Nicoletta Erba, Alberto Tosetto, Martin Langer, Suha Abdelwahab Abdallah, Elena Giovanella, Salvatore Lentini, Franco Masini, Alessandro Mocini, Gennarina Portella, Alessandro Cristian Salvati, Alessandro Squizzato, Sophie Testa, Gregory Y.H. Lip, Daniela Poli
Thrombosis Research vol: 219 first page: 155 year: 2022
doi: 10.1016/j.thromres.2022.09.018
2. QUALITY OF ANTI-COAGULATION, PREDICTORS, AND CONSEQUENCES OF DERANGED INR OF PATIENTS ON WARFARIN THERAPY
AKANKSHA MATHUR, ACHAL SHARMA
Asian Journal of Pharmaceutical and Clinical Research first page: 80 year: 2024
doi: 10.22159/ajpcr.2024v17i12.52969
3. Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda
Innocent G. Asiimwe, Catriona Waitt, Christine Sekaggya‐Wiltshire, Claire Hutchinson, Emmy Okello, Eunice J. Zhang, Jerome R. Semakula, Johannes P. Mouton, Karen Cohen, Marc Blockman, Mohammed Lamorde, Andrea L. Jorgensen, Munir Pirmohamed
Clinical Pharmacology & Therapeutics vol: 109 issue: 6 first page: 1564 year: 2021
doi: 10.1002/cpt.2128
4. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia
Nuredin Shiferaw Yimer, Alfoalem Araba Abiye, Shemsu Umer Hussen, Tamrat Assefa Tadesse
Clinical and Applied Thrombosis/Hemostasis vol: 27 year: 2021
doi: 10.1177/10760296211049786
5. Assessment of knowledge and practice of cardiovascular nurses regarding warfarin
Maryam Ehsani, Mansoureh Ashghali Farahani, Shima Haghani, Shiva Khaleghparast, Mahboubeh Malekmohammadi Memar
Journal of Education and Health Promotion vol: 11 issue: 1 first page: 270 year: 2022
doi: 10.4103/jehp.jehp_1240_21
6. Anticoagulation Management in Patients Receiving Warfarin at Private Cardiac Centers in Addis Ababa, Ethiopia
Roza Getachew, Tamrat Assefa Tadesse, Bekele Alemayehu Shashu, Amsalu Degu, Getachew Alemkere
Journal of Blood Medicine vol: Volume 14 first page: 107 year: 2023
doi: 10.2147/JBM.S397189
7. Standard-of-care versus pharmacist-supported interventions to improve anticoagulation control in Namibia
Moses Thikukutu, Lauren Jonkman, Bonifasius Singu, Mubita Mwangana, Fenny Shidhika, Roger K. Verbeeck
Discover Health Systems vol: 4 issue: 1 year: 2025
doi: 10.1007/s44250-025-00278-8
8. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa
Jerome Roy Semakula, Johannes P. Mouton, Andrea Jorgensen, Claire Hutchinson, Shaazia Allie, Lynn Semakula, Neil French, Mohammed Lamorde, Cheng-Hock Toh, Marc Blockman, Christine Sekaggya-Wiltshire, Catriona Waitt, Munir Pirmohamed, Karen Cohen, Joel Msafiri Francis
PLOS ONE vol: 15 issue: 1 first page: e0227458 year: 2020
doi: 10.1371/journal.pone.0227458
9. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes
Sarudzai Muyambo, Arinao Ndadza, Nyarai D. Soko, Bianca Kruger, Gerard Kadzirange, Emile Chimusa, Collen M. Masimirembwa, Mpiko Ntsekhe, Charles F.B. Nhachi, Collet Dandara
OMICS: A Journal of Integrative Biology vol: 26 issue: 1 first page: 35 year: 2022
doi: 10.1089/omi.2021.0199
10. Magnitude of hemorrhagic complications and its associated factors among patients on anticoagulant therapy at University of Gondar Comprehensive and Specialized Hospital, Northwest Ethiopia
Eden Abetu Mehari, Abebe Basazn Mekuria, Mestayet Geta, Eshetie Melese Birru
Thrombosis Update vol: 10 first page: 100130 year: 2023
doi: 10.1016/j.tru.2023.100130
11. Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review
Tamrat Assefa Tadesse, Gobezie Temesgen Tegegne, Dejuma Yadeta, Legese Chelkaba, Teferi Gedif Fenta
Thrombosis Journal vol: 20 issue: 1 year: 2022
doi: 10.1186/s12959-022-00416-9
12. Atrial fibrillation in low- and middle-income countries: a narrative review
Itamar S Santos, Alessandra C Goulart, Rodrigo D Olmos, G Neil Thomas, Gregory Y H Lip, Paulo A Lotufo, Isabela M Benseñor, Ajini Arasalingam, Isabela Benseñor, Peter Brocklehurst, Kar Keung Cheng, Mei Feng, Alessandra C Goulart, Sheila Greenfield, Yutao Guo, Mahesan Guruparan, Gustavo Gusso, Wang Hao, Lindsey Humphreys, Balachandran Kumarendran, Kate Jolly, Sue Jowett, Emma Lancashire, Deirdre A Lane, Xuewen Li, Yanguang Li, Gregory Y H Lip, Trudie Lobban, Paulo Lotufo, Semira Manseki-Holland, David Moore, Krishnarajah Nirantharakumar, Rodrigo Olmos, Itamar S Santos, Alena Shantsila, Isabelle Szmigin, Kumaran Subaschandren, Rajendra Surenthirakumaran, G Neil Thomas, Jingya Wang
European Heart Journal Supplements vol: 22 issue: Supplement_O first page: O61 year: 2020
doi: 10.1093/eurheartj/suaa181
13. Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort
Nicoletta Erba, Alberto Tosetto, Suha Abdelwahab Abdallah, Martin Langer, Elena Giovanella, Salvatore Lentini, Franco Masini, Alessandro Mocini, Gennarina Portella, Alessandro Cristian Salvati, Alessandro Squizzato, Sophie Testa, Daniela Poli
Thrombosis Research vol: 244 first page: 109183 year: 2024
doi: 10.1016/j.thromres.2024.109183
14. Anticoagulation quality through time in therapeutic range in Sub-Saharan Africa: a systematic review and meta-analysis
Desalegn Getnet Demsie, Zenaw Debasu Addisu, Chernet Tafere, Kebede Feyisa, Bereket Bahiru, Malede Berihun Yismaw, Getahun Mihret, Abere Tilahun, Desye Gebrie, Derbew Fikadu Berhe
Frontiers in Medicine vol: 12 year: 2025
doi: 10.3389/fmed.2025.1517162
15. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population
Letícia C. Tavares, Nubia E. Duarte, Leiliane R. Marcatto, Renata A. G. Soares, Jose E. Krieger, Alexandre C. Pereira, Paulo Caleb Junior Lima Santos
European Journal of Clinical Pharmacology vol: 74 issue: 12 first page: 1555 year: 2018
doi: 10.1007/s00228-018-2528-z
16. Evaluation of Anticoagulation Control among Patients Taking Warfarin in University of Gondar Hospital, Northwest Ethiopia
Zelalem Liyew, Abilo Tadesse, Nebiyu Bekele, Tewodros Tsegaye, Elvira Grandone
Advances in Hematology vol: 2021 first page: 1 year: 2021
doi: 10.1155/2021/7530997
17. The Genetics of Warfarin Dose–Response Variability in Africans: An Expert Perspective on Past, Present, and Future
Arinao Ndadza, Nicholas Ekow Thomford, Stanley Mukanganyama, Ambroise Wonkam, Mpiko Ntsekhe, Collet Dandara
OMICS: A Journal of Integrative Biology vol: 23 issue: 3 first page: 152 year: 2019
doi: 10.1089/omi.2019.0018
18. Stroke prevention in atrial fibrillation: State of the art
Yan-Guang Li, Gregory Y.H. Lip
International Journal of Cardiology vol: 287 first page: 201 year: 2019
doi: 10.1016/j.ijcard.2018.09.057
19. A review of the epidemiology of atrial fibrillation in sub‐Saharan Africa
Jean Jacques Noubiap, Ulrich Flore Nyaga
Journal of Cardiovascular Electrophysiology vol: 30 issue: 12 first page: 3006 year: 2019
doi: 10.1111/jce.14222
20. The adequacy and safety of anticoagulation therapy with warfarin at the medical outpatient clinic of an academic hospital
TA Pilane, MJ Mpe
SA Pharmaceutical Journal vol: 92 issue: 1 first page: 39 year: 2025
doi: 10.36303/SAPJ.0963
21. Association of sex with major bleeding risks in sub-Saharian anticoagulated patients with mechanical heart valves: A cohort study from the Khartoum Emergency Salam Centre.
Nicoletta Erba, Alberto Tosetto, Suha Abdelwahab Abdallah, Martin Langer, Elena Giovanella, Salvatore Lentini, Franco Masini, Alessandro Mocini, Gennarina Portella, Alessandro Cristian Salvati, Alessandro Squizzato, Sophie Testa, Gregory Y.H. Lip, Daniela Poli
International Journal of Cardiology vol: 394 first page: 131398 year: 2024
doi: 10.1016/j.ijcard.2023.131398
22. Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis
Desalegn Getnet Demsie, Zenaw Debasu Addisu, Chernet Tafere, Bereket Bahiru, Malede Berihun Yismaw, Getahun Mihret, Derbew Fikadu Berhe
Pharmacoepidemiology and Drug Safety vol: 34 issue: 10 year: 2025
doi: 10.1002/pds.70225
23. Atrial Fibrillation in Africa—An Under-Reported and Unrecognized Risk
Factor for Stroke: A Systematic Review
Maartje S. Jacobs, Marinus Van Hulst, Abiodun M. Adeoye, Robert G. Tieleman, Maarten J. Postma, Mayowa O. Owolabi
Global Heart vol: 14 issue: 3 first page: 269 year: 2019
doi: 10.1016/j.gheart.2019.04.003
24. Evaluation of Warfarin Anticoagulation at University of Gondar Comprehensive Specialized Hospital, North-West Ethiopia
Nahusenay Masresha, Esileman Abdela Muche, Asmamaw Atnafu, Ousman Abdela
Journal of Blood Medicine vol: Volume 12 first page: 189 year: 2021
doi: 10.2147/JBM.S282948
25. Oral Anticoagulant Management in Sub-Saharian African Patients with Mechanical Heart Valves: Observations on Quality of Anticoagulation and Thrombotic Risk
Nicoletta Erba, Alberto Tosetto, Martin Langer, Suha Abdelwahab Abdallah, Elena Giovanella, Salvatore Lentini, Franco Masini, Alessandro Mocini, Gina Portella, Alessandro Salvati, Squizzato Alessandro, Sophie Testa, Gregory Lip, Daniela Poli
SSRN Electronic Journal year: 2022
doi: 10.2139/ssrn.4164076